nach oben

Archives of Virology

Erschienen in:

01.12.2014 | Brief Review

Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence

verfasst von: E. A. Goka, P. J. Vallely, K. J. Mutton, P. E. Klapper

Erschienen in: Archives of Virology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Mutations in the haemagglutinin (HA), non-structural protein 1 (NS1) and polymerase basic protein 2 (PB2) of influenza viruses have been associated with virulence. This study investigated the association between mutations in these genes in influenza A(H1N1)pdm09 virus and the risk of severe or fatal disease. Searches were conducted on the MEDLINE, EMBASE and Web of Science electronic databases and the reference lists of published studies. The PRISMA and STROBE guidelines were followed in assessing the quality of studies and writing-up. Eighteen (18) studies, from all continents, were included in the systematic review (recruiting patients 0 – 77 years old). The mutation D222G was associated with a significant increase in severe disease (pooled RD: 11 %, 95 % CI: 3.0 % - 18.0 %, p = 0.004) and the risk of fatality (RD: 23 %, 95 % CI: 14.0 %–31.0 %, p = < 0.0001). No association was observed between the mutations HA-D222N, D222E, PB2-E627K and NS1-T123V and severe/fatal disease. The results suggest that no virus quasispecies bearing virulence-conferring mutations in the HA, PB2 and NS1 predominated. However issues of sampling bias, and bias due to uncontrolled confounders such as comorbidities, and viral and bacterial coinfection, should be born in mind. Influenza A viruses should continue to be monitored for the occurrence of virulence-conferring mutations in HA, PB2 and NS1. There are suggestions that respiratory virus coinfections also affect virus virulence. Studies investigating the role of genetic mutations on disease outcome should make efforts to also investigate the role of respiratory virus coinfections.

Nur mit Berechtigung zugänglich

Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453:615–619PubMedCentralPubMed

Scholtissek C, Rohde W, Von Hoyningen V, Rott R (1978) On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87:13–20PubMed

Kawaoka Y, Webster RG (1988) Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci 85:324–328PubMedCentralPubMed

Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, St GK, Taylor J, Spiro DJ, Sengamalay NA, Ghedin E, Taubenberger JK, Holmes EC (2008) Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 4:e1000012PubMedCentralPubMed

Morens DM, Taubenberger JK, Fauci AS (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361:225–229PubMedCentralPubMed

Zimmer SM, Burke DS (2009) Historical perspective–Emergence of influenza A (H1N1) viruses. N Engl J Med 361:279–285PubMed

Horimoto T, Kawaoka Y (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3:591–600PubMed

Wilson IA, Cox NJ (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8:737–771PubMed

McDonald NJ, Smith CB, Cox NJ (2007) Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. J Gen Virol 88:12–13

10.

Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, Wilson IA (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357–360PubMedCentralPubMed

11.

Liao YC, Chen FC, Hsiung CA (2010) Contrasting substitution patterns between HA proteins of avian and human influenza viruses: implication for monitoring human influenza epidemics. Vaccine 28:7890–7896PubMed

12.

Shen J, Ma J, Wang Q (2009) Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918. PLoS One 4:e7789PubMedCentralPubMed

13.

Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A (2010) Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One 5:e8553PubMedCentralPubMed

14.

Nobusawa E, Nakajima K, Nakajima S (1987) Determination of the epitope 264 on the hemagglutinin molecule of influenza H1N1 virus by site-specific mutagenesis. Virology 159:10–19PubMed

15.

Hatta M, Gao P, Halfmann P, Kawaoka Y (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840–1842PubMed

16.

Munster VJ, de WE, van RD, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Kuiken T, Fouchier RA (2007) The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 196:258–265PubMed

17.

Van HN, Pappas C, Belser JA, Maines TR, Zeng H, Garcia-Sastre A, Sasisekharan R, Katz JM, Tumpey TM (2009) Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. PLoS One 106:3366–3371

18.

Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, Garcia-Sastre A (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. PLoS One 99:10736–10741

19.

Seo SH, Webster RG (2002) Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol 76:1071–1076PubMedCentralPubMed

20.

Matsuoka Y, Swayne DE, Thomas C, Rameix-Welti MA, Naffakh N, Warnes C, Altholtz M, Donis R, Subbarao K (2009) Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J Virol 83:4704–4708PubMedCentralPubMed

21.

Tumpey TM, Maines TR, Van HN, Glaser L, Solorzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, Garcia-Sastre A (2007) A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655–659PubMed

22.

Vines A, Wells K, Matrosovich M, Castrucci MR, Ito T, Kawaoka Y (1998) The Role of influenza A virus hemagglutinin residues 226á and 228á in receptor specificity and host range restriction. J Virol 72:7626–7631PubMedCentralPubMed

23.

Connor RJ, Kawaoka Y, Webster RG, Paulson JC (1994) Receptor specificity in human, avian, and equine H2 and H3 Influenza virus isolates. Virology 205:17–23PubMed

24.

Matrosovich MN, Gambaryan AS, Teneberg SP, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Karlsson KA (2001) Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 233(1):224–234

25.

Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569PubMed

26.

Srinivasan A, Viswanathan K, Raman R, Chandrasekaran A, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R (2008) Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. PLoS One 105:2800–2805

27.

Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, Wilson IA (2006) Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355:1143–1155PubMed

28.

Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, Ha Y, Vasisht N, Steinhauer DA, Daniels RS, Elliot A, Wiley DC, Skehel JJ (2004) The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303:1838–1842PubMed

29.

Zhang Y, Zhang Q, Gao Y, He X, Kong H, Jiang Y, Guan Y, Xia X, Shu Y, Kawaoka Y, Bu Z, Chen H (2012) Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J Virol 86:9666–9674PubMedCentralPubMed

30.

Caton AJ, Brownlee GG, Yewdell JW, Gerhard W (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417–427PubMed

31.

Luoh SM, McGregor MW, Hinshaw VS (2002) Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses. J Virol 66(2):1066–1073

32.

Gerhard W, ewdell J, ankel ME, bster R (1958) Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290(5808):713–777

33.

Brownlee GG, Fodor E (2001) The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 356(1416):1871–1876PubMedCentralPubMed

34.

Cox NJ, Black RA, Kendal AP (1989) Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. J Gen Virol 70:299–313PubMed

35.

Huang JW, Lin WF, Yang JM (2012) Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays. Vaccine 30:6327–6337PubMed

36.

Stray SJ, Pittman LB (2012) Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin. Virol J 9:91. doi:10.1186/1743-422X-9-91 PubMedCentralPubMed

37.

Garten W, Klenk HD (1999) Understanding influenza virus pathogenicity. Trends Microbiol 7:99–100PubMed

38.

Schwarz F, Aebi M (2011) Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol 21:576–582PubMed

39.

Sun X, Jayaraman A, Maniprasad P, Raman R, Houser KV, Pappas C, Zeng H, Sasisekharan R, Katz JM, Tumpey TM (2013) N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses. J Virol 87:8756–8766PubMedCentralPubMed

40.

Sun S, Wang Q, Zhao F, Chen W, Li Z (2011) Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS One 6:e22844PubMedCentralPubMed

41.

Huang TS, Palese P, Krystal M (1990) Determination of influenza virus proteins required for genome replication. J Virol 64:5669–5673PubMedCentralPubMed

42.

Li ML, Rao P, Krug RM (2001) The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J 20:2078–2086PubMedCentralPubMed

43.

Honda A, Mizumoto K, Ishihama A (1999) Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase. Genes Cells 4:475–485PubMed

44.

Palese P, Shaw ML (2007) Othomyxoviridae: The viruses and their Replication. In: Knipe DM, Griffin DE, Lamb RA, Straus SE, Howley PM, Martin MA, Roizman B (eds) Fields Virology. Lippincott Williams and Wilkins, Philadelphia, pp 1647–1689

45.

Fechter P, Mingay L, Sharps J, Chambers A, Fodor E, Brownlee GG (2003) Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J Biol Chem 278:20381–20388PubMed

46.

Poole E, Elton D, Medcalf L, Digard P (2004) Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology 321:120–133PubMed

47.

Subbarao EK, London W, Murphy BR (1993) A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67:1761–1764PubMedCentralPubMed

48.

Herfst S, Chutinimitkul S, Ye J, de WE, Munster VJ, Schrauwen EJ, Bestebroer TM, Jonges M, Meijer A, Koopmans M, Rimmelzwaan GF, Osterhaus AD, Perez DR, Fouchier RA (2010) Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol 84:3752–3758PubMedCentralPubMed

49.

Gabriel G, Herwig A, Klenk HD (2008) Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog 4:e11PubMedCentralPubMed

50.

Miotto O, Heiny AT, Albrecht R, Garcia-Sastre A, Tan TW, August JT, Brusic V (2010) Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One 5:e9025PubMedCentralPubMed

51.

Zhou B, Pearce MB, Li Y, Wang J, Mason RJ, Tumpey TM, Wentworth DE (2013) Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus. PLoS One 8:e67616PubMedCentralPubMed

52.

Jagger BW, Memoli MJ, Sheng ZM, Qi L, Hrabal RJ, Allen GL, Dugan VG, Wang R, Digard P, Kash JC, Taubenberger JK (2010) The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymerase. MBio 1:1 (pii: e00067–10)

53.

Zhao Z, Yi C, Zhao L, Wang S, Zhou L, Hu Y, Zou W, Chen H, Jin M (2014) PB2-588I Enhances 2009 H1N1 Pandemic Influenza Virus Virulence by Increasing Viral Replication and Exacerbating PB2 Inhibition of Beta Interferon Expression. J Virol 88:2260–2267PubMedCentralPubMed

54.

Liu Q, Qiao C, Marjuki H, Bawa B, Ma J, Guillossou S, Webby RJ, Richt JA, Ma W (2012) Combination of PB2 271A and SR polymorphism at positions 590/591 is critical for viral replication and virulence of swine influenza virus in cultured cells and in vivo. J Virol 86:1233–1237PubMedCentralPubMed

55.

Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T (2010) PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol 84:4395–4406PubMedCentralPubMed

56.

Zhu H, Wang J, Wang P, Song W, Zheng Z, Chen R, Guo K, Zhang T, Peiris JS, Chen H, Guan Y (2010) Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology 401:1–5PubMedCentralPubMed

57.

Yamada S, Hatta M, Staker BL, Watanabe S, Imai M, Shinya K, Sakai-Tagawa Y, Ito M, Ozawa M, Watanabe T, Sakabe S, Li C, Kim JH, Myler PJ, Phan I, Raymond A, Smith E, Stacy R, Nidom CA, Lank SM, Wiseman RW, Bimber BN, O’Connor DH, Neumann G, Stewart LJ, Kawaoka Y (2010) Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog 6:e1001034PubMedCentralPubMed

58.

Zhou B, Li Y, Halpin R, Hine E, Spiro DJ, Wentworth DE (2011) PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice. J Virol 85:357–365PubMedCentralPubMed

59.

Zhu W, Zhu Y, Qin K, Yu Z, Gao R, Yu H, Zhou J, Shu Y (2012) Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice. PLoS One 7:e33383PubMedCentralPubMed

60.

Mehle A, Doudna JA (2009) Adaptive strategies of the influenza virus polymerase for replication in humans. PLoS One 106:21312–21316

61.

Qian XY, Alonso-Caplen F, Krug RM (1994) Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol 68:2433–2441PubMedCentralPubMed

62.

Lin D, Lan J, Zhang Z (2007) Structure and function of the NS1 protein of influenza A virus. Acta Biochim Biophys Sin 39:155–162PubMed

63.

Li Y, Chen ZY, Wang W, Baker CC, Krug RM (2001) The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. Rna-A Rna Soc 7:920–931

64.

Kochs G, Garcia-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011–7021PubMedCentralPubMed

65.

Qiu Y, Krug RM (1994) The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68:2425–2432PubMedCentralPubMed

66.

Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM (1999) RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5:195–205PubMedCentralPubMed

67.

Cheng A, Wong SM, Yuan YA (2009) Structural basis for dsRNA recognition by NS1 protein of influenza A virus. Cell Res 19:187–195PubMed

68.

Yin C, Khan JA, Swapna GV, Ertekin A, Krug RM, Tong L, Montelione GT (2007) Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J Biol Chem 282:20584–20592PubMed

69.

Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T (2000) Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74:6203–6206PubMedCentralPubMed

70.

Min JY, Li S, Sen GC, Krug RM (2007) A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363:236–243PubMed

71.

Hale BG, Randall RE, Ortin J, Jackson D (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:10–76

72.

Pu J, Wang J, Zhang Y, Fu G, Bi Y, Sun Y, Liu J (2010) Synergism of co-mutation of two amino acid residues in NS1 protein increases the pathogenicity of influenza virus in mice. Virus Res 151:200–204PubMed

73.

Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A (2009) Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439–449PubMedCentralPubMed

74.

Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, Garcia-Sastre A (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524PubMedCentralPubMed

75.

Bornholdt ZA, Prasad BV (2006) X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 13:559–560PubMed

76.

Chien Cy XuY, Xiao R, Aramini JM, Sahasrabudhe PV, Krug RM, Montelione GT (2004) Biophysical Characterization of the Complex between Double-Stranded RNA and the N-Terminal Domain of the NS1 Protein from Influenza A Virus:GÇë Evidence for a Novel RNA-Binding ModeGÇá. Biochemistry 43:1950–1962PubMed

77.

Donelan NR, Basler CF, Garcia-Sastre A (2003) A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77:13257–13266PubMedCentralPubMed

78.

Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996PubMedCentralPubMed

79.

Mok BW, Song W, Wang P, Tai H, Chen Y, Zheng M, Wen X, Lau SY, Wu WL, Matsumoto K, Yuen KY, Chen H (2012) The NS1 protein of influenza A virus interacts with cellular processing bodies and stress granules through RNA-associated protein 55 (RAP55) during virus infection. J Virol 86:12695–12707PubMedCentralPubMed

80.

Giria MT, de Rebelo AH, Santos LA, Correia VM, Pedro SV, Santos MA (2012) Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09. J Clin Virol 53:140–144PubMed

81.

Minor PD (2010) Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production. Clin Infect Dis 50:560–565PubMed

82.

WHO (2007) A description of the process of seasonal and H5N1 influenza vaccine virus selection and development

83.

Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I (2009) Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 4:e5079PubMedCentralPubMed

84.

Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De SG (2007) Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine 25:2842–2851PubMed

85.

Valenciano M, Kissling E, Ciancio BC, Moren A (2010) Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 28:7381–7388PubMed

86.

De SG, Skowronski DM, Wu XW, Ambrose CS (2013) The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 18:20585

87.

Lakdawala SS, Shih AR, Jayaraman A, Lamirande EW, Moore I, Paskel M, Sasisekharan R, Subbarao K (2013) Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets. Virology 446:349–356PubMed

88.

Zhang Y, Zhu J, Li Y, Bradley KC, Cao J, Chen H, Jin M, Zhou H (2013) Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic H1N1/2009 influenza A virus in mice. PLoS One 8:e61397PubMedCentralPubMed

89.

Kim JI, Lee I, Park S, Hwang MW, Bae JY, Lee S, Heo J, Park MS, Garcia-Sastre A, Park MS (2013) Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. J Virol 87:7539–7549PubMedCentralPubMed

90.

Zou W, Chen D, Xiong M, Zhu J, Lin X, Wang L, Zhang J, Chen L, Zhang H, Chen H, Chen M, Jin M (2013) Insights into the increasing virulence of the swine-origin pandemic H1N1/2009 influenza virus. Sci Rep 3:1601. doi:10.1038/srep01601 PubMedCentralPubMed

91.

Uraki R, Kiso M, Shinya K, Goto H, Takano R, Iwatsuki-Horimoto K, Takahashi K, Daniels RS, Hungnes O, Watanabe T, Kawaoka Y (2013) Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model. J Virol 87:2226–2233PubMedCentralPubMed

92.

Pan D, Xue W, Wang X, Guo J, Liu H, Yao X (2012) Molecular mechanism of the enhanced virulence of 2009 pandemic influenza A (H1N1) virus from D222G mutation in the hemagglutinin: a molecular modeling study. J Mol Model 18:4355–4366PubMed

93.

Seyer R, Hrincius ER, Ritzel D, Abt M, Mellmann A, Marjuki H, Kuhn J, Wolff T, Ludwig S, Ehrhardt C (2012) Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice. J Infect Dis 205:262–271PubMed

94.

Belser JA, Jayaraman A, Raman R, Pappas C, Zeng H, Cox NJ, Katz JM, Sasisekharan R, Tumpey TM (2011) Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS One 6:e25091PubMedCentralPubMed

95.

WHO (2009) Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. http://www.who.int/csr/resources/publications/swineflu/cp165_2009_2812_review_d222g_amino_acid_substitution_in_ha_h1n1_viruses.pdf. Accessed on 15 Jul 2012

96.

ECDPC (2010) The 2009 A(H1N1) pandemic in Europe: A review of the experience. http://www.ecdc.europa.eu/en/publications/Publications/101108_SPR_pandemic_experience.pdf. Accessed on 10 Dec 2012

97.

Richard N, Komurian-Pradel F, Javouhey E, Perret M, Rajoharison A, Bagnaud A, Billaud G, Vernet G, Lina B, Floret D, Paranhos-Baccala G (2008) The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J 27:213–217PubMed

98.

Drews AL, Atmar RL, Glezen WP, Baxter BD, Piedra PA, Greenberg SB (1997) Dual respiratory virus infections. Clin Infect Dis 25:1421–1429PubMed

99.

Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C, Shears P, Smyth RL, Hart CA (2005) Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 191:382–386PubMed

100.

Rhedin S, Hamrin J, Naucler P, Bennet R, Rotzen-Ostlund M, Farnert A, Eriksson M (2012) Respiratory viruses in hospitalized children with influenza-like illness during the H1n1 2009 pandemic in Sweden. PLoS One 7:e51491PubMedCentralPubMed

101.

Echenique IA, Chan PA, Chapin KC, Andrea SB, Fava JL, Mermel LA (2013) Clinical characteristics and outcomes in hospitalized patients with respiratory viral co-infection during the 2009 H1N1 influenza pandemic. PLoS One 8:e60845PubMedCentralPubMed

102.

Marcone DN, Ellis A, Videla C, Ekstrom J, Ricarte C, Carballal G, Vidaurreta SM, Echavarria M (2013) Viral etiology of acute respiratory infections in hospitalized and outpatient children in Buenos Aires, Argentina. Pediatr Infect Dis J 32:e105–e110PubMed

103.

Goka E, Vallely P, Mutton K, Klapper P (2013) Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality. Influenza Other Respi Viruses 7:1079–1087

104.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. doi:10.1136/bmj.b2700 PubMedCentralPubMed

105.

von EE, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457

106.

WHO (2009) Clinical management of human infection with pandemic (H1N1) 2009: revised guidance (Nov 2009). http://www.who.int/csr/resources/publications/swineflu/clinical_management_h1n1.pdf?ua=1.Accessed 1 Oct 2012

107.

Potdar VA, Chadha MS, Jadhav SM, Mullick J, Cherian SS, Mishra AC (2010) Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One 5:e9693PubMedCentralPubMed

108.

Tse H, To KK, Wen X, Chen H, Chan KH, Tsoi HW, Li IW, Yuen KY (2011) Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS One 6:e22534PubMedCentralPubMed

109.

Baldanti F, Campanini G, Piralla A, Rovida F, Braschi A, Mojoli F, Iotti G, Belliato M, Conaldi PG, Arcadipane A, Pariani E, Zanetti A, Minoli L, Emmi V (2011) Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicentre study. Clin Microbiol Infect 17:1166–1169PubMed

110.

Promed Email (2009) Influenza pandemic (H1N1) 2009 (58): The Netherlands, PB2 Mutation. http://www.influenzah5n1.fr/index.php?topic=11880.0;wap2 Accessed on 20 Nov 2013

111.

Puzelli S, Facchini M, De Marco MA, Palmieri A, Spagnolo D, Boros S, Corcioli F, Trotta D, Bagnarelli P, Azzi A, Cassone A, Rezza G, Pompa MG, Oleari F, Donatelli I (2010) Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. Euro Surveill 15:43 (pii: 19696)

112.

Kilander A, Rykkvin R, Dudman SG, Hungnes O (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15:9 (pii: 19498)

113.

Mak GC, Au KW, Tai LS, Chuang KC, Cheng KC, Shiu TC, Lim W (2010) Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15:14 (pii: 19534)

114.

Miller RR, MacLean AR, Gunson RN, Carman WF (2010) Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill 15:16 (pii: 19546)

115.

Graham M, Liang B, Van DG, Bastien N, Beaudoin C, Tyler S, Kaplen B, Landry E, Li Y (2011) Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009. PLoS One 6:e16087PubMedCentralPubMed

116.

Farooqui A, Lei Y, Wang P, Huang J, Lin J, Li G, Leon AJ, Zhao Z, Kelvin DJ (2011) Genetic and clinical assessment of 2009 pandemic influenza in southern China. J Infect Dev Ctries 5:700–710PubMed

117.

Chen H, Wen X, To KK, Wang P, Tse H, Chan JF, Tsoi HW, Fung KS, Tse CW, Lee RA, Chan KH, Yuen KY (2010) Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis 201:1517–1521PubMed

118.

Venter M, Naidoo D, Pretorius M, Buys A, McAnerney J, Blumberg L, Madhi SA, Cohen C, Schoub B (2012) Evolutionary dynamics of 2009 pandemic influenza A virus subtype H1N1 in South Africa during 2009-2010. J Infect Dis 206(Suppl 1):S166–S172. doi:10.1093/infdis/jis539 PubMed

119.

Akcay CM, Hasoksuz M, Kanturvardar M, Asar S, Badur S (2013) Molecular and serological investigations of the Influenza A(H1N1) 2009 pandemic virus in Turkey. Med Microbiol Immunol 202:277–284

120.

Vazquez-Perez JA, Isa P, Kobasa D, Ormsby CE, Ramirez-Gonzalez JE, Romero-Rodriguez DP, Ranadheera C, Li Y, Bastien N, Embury-Hyatt C, Gonzalez-Duran E, Barrera-Badillo G, Ablanedo-Terrazas Y, Sevilla-Reyes EE, Escalera-Zamudio M, Cobian-Guemes AG, Lopez I, Ortiz-Alcantara J, Alpuche-Aranda C, Perez-Padilla JR, Reyes-Teran G (2013) A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in Mexico. Virol J 10:41. doi:10.1186/1743-422X-10-41 PubMedCentralPubMed

121.

Wedde M, Wahlisch S, Wolff T, Schweiger B (2013) Predominance of HA-222D/G polymorphism in influenza A(H1N1)pdm09 viruses associated with fatal and severe outcomes recently circulating in Germany. PLoS One 8:e57059PubMedCentralPubMed

122.

Moussi AE, Kacem MA, Pozo F, Ledesma J, Cuevas MT, Casas I, Slim A (2013) Frequency of D222G haemagglutinin mutant of pandemic (H1N1) pdm09 influenza virus in Tunisia between 2009 and 2011. Diagn Pathol 8:124–128PubMedCentralPubMed

123.

Ferreira JL, Borborema SE, Brigido LF, Oliveira MI, Paiva TM, Santos CL (2011) Sequence analysis of the 2009 pandemic influenza A H1N1 virus haemagglutinin gene from 2009–2010 Brazilian clinical samples. Mem Inst Oswaldo Cruz 106:613–616PubMed

124.

Barrero PR, Viegas M, Valinotto LE, Mistchenko AS (2011) Genetic and phylogenetic analyses of influenza A H1N1pdm virus in Buenos Aires, Argentina. J Virol 85:1058–1066PubMedCentralPubMed

125.

Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW (2013) Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respi Viruses 7(5):872–886. doi:10.1111/irv.12074

126.

Glinsky GV (2010) Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle 9:958–970PubMed

127.

Lee RT, Santos CL, de Paiva TM, Cui L, Sirota FL, Eisenhaber F, Maurer-Stroh S (2010) All that glitters is not gold–founder effects complicate associations of flu mutations to disease severity. Virol J 7:297PubMedCentralPubMed

128.

PHE (2010) Epidemiological report of pandemic (H1N1) 2009 in the UK. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1284475321350 Accessed on 1 December 2011

129.

Murphy BR, Buckler-White AJ, London WT, Snyder MH (1989) Characterization of the M protein and nucleoprotein genes of an avian influenza A virus which are involved in host range restriction in monkeys. Vaccine 7:557–561PubMed

130.

Clements ML, Subbarao EK, Fries LF, Karron RA, London WT, Murphy BR (1992) Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J Clin Microbiol 30:655–662PubMedCentralPubMed

131.

Pascalis H, Temmam S, Wilkinson DA, Dsouli N, Turpin M, de LX, Dellagi K (2012) Molecular evolutionary analysis of pH1N1 2009 influenza virus in Reunion Island, South West Indian Ocean region: a cohort study. PLoS One 7:e43742PubMedCentralPubMed

132.

Mullick J, Cherian SS, Potdar VA, Chadha MS, Mishra AC (2011) Evolutionary dynamics of the influenza A pandemic (H1N1) 2009 virus with emphasis on Indian isolates: evidence for adaptive evolution in the HA gene. Infect Genet Evol 11:997–1005PubMed

133.

Punpanich W, Chotpitayasunondh T (2012) A review on the clinical spectrum and natural history of human influenza. Int J Infect Dis 16:e714–e723PubMed

134.

Ruuskanen O, Lahti E, Jennings LC, Murdoch DR (2011) Viral pneumonia. Lancet 377:1264–1275PubMed

135.

Cilla G, Onate E, Perez-Yarza EG, Montes M, Vicente D, Perez-Trallero E (2008) Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol 80:1843–1849PubMed

136.

Guerrier G, Goyet S, Chheng ET, Rammaert B, Borand L, Te V, Try PL, Sareth R, Cavailler P, Mayaud C, Guillard B, Vong S, Buchy P, Tarantola A (2013) Acute viral lower respiratory tract infections in Cambodian children: clinical and epidemiologic characteristics. Pediatr Infect Dis J 32:e8–e13PubMed

137.

Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S, Ruggeberg JU, Willers R, Henrich B, Schroten H, Tenenbaum T (2010) Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 48:239–245PubMed

138.

Do AHL, van Doorn HR, Nghiem MN, Bryant JE, Hoang THt, Do QH, Le Van T, Tran TT, Wills B, Nguyen VCv, Vo MH, Vo CK, Nguyen MD, Farrar J, Tran TH, de Jong MD (2011) Viral Etiologies of Acute Respiratory Infections among Hospitalized Vietnamese Children in Ho Chi Minh City, 2004GÇô2008. PLoS One 6:e18176PubMedCentralPubMed

139.

Peltola VT, McCullers JA (2004) Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 23:S87–S97PubMed

140.

Bakaletz LO (1995) Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 3:110–114PubMed

141.

Li W, Shi W, Qiao H, Ho SY, Luo A, Zhang Y, Zhu C (2011) Positive selection on hemagglutinin and neuraminidase genes of H1N1 influenza viruses. Virol J 8:183. doi:10.1186/1743-422X-8-183 PubMedCentralPubMed

142.

Shih AC, Hsiao TC, Ho MS, Li WH (2007) Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci USA 104:6283–6288PubMedCentralPubMed

143.

Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373–378PubMed

144.

Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM (1999) Predicting the evolution of human influenza A. Science 286:1921–1925PubMed

145.

Suzuki Y, Gojobori T (1999) A method for detecting positive selection at single amino acid sites. Mol Biol Evol 16:1315–1328PubMed

146.

Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, Hongo S (2004) Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 78:9605–9611PubMedCentralPubMed

147.

Blackburne BP, Hay AJ, Goldstein RA (2008) Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog 4:e1000058PubMedCentralPubMed

148.

Seidel W, Kunkel F, Geisler B, Garten W, Herrmann B, Dohner L, Klenk HD (1991) Intraepidemic variants of influenza virus H3 hemagglutinin differing in the number of carbohydrate side chains. Arch Virol 120:289–296PubMed

149.

Deem MW, Pan K (2009) The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. Protein Eng Des Sel 22:543–546PubMedCentralPubMed

150.

Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305:371–376PubMed

151.

Anisimova M, Kosiol C (2009) Investigating protein-coding sequence evolution with probabilistic codon substitution models. Mol Biol Evol 26:255–271PubMed

152.

Delport W, Scheffler K, Botha G, Gravenor MB, Muse SV, Kosakovsky Pond SL (2010) CodonTest: modeling amino acid substitution preferences in coding sequences. PLoS Comput Biol 6:e1000885PubMedCentralPubMed

153.

Hall TA (1999) Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98

Titel: Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence
verfasst von: E. A. Goka
P. J. Vallely
K. J. Mutton
P. E. Klapper
Publikationsdatum: 01.12.2014
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 12/2014
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-014-2179-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2014

Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004–2007 and 2008–2011

Complete genome analysis of a novel recombinant isolate of potato virus Y from China

Development of a tetra-primer ARMS PCR-based assay for detection of a novel single-nucleotide polymorphism in the 5′ untranslated region of the bovine ITGB6 receptor gene associated with foot-and-mouth disease susceptibility in cattle

Improvements to pairwise sequence comparison (PASC): a genome-based web tool for virus classification

Comparative analysis of LTR and structural genes in an equine infectious anemia virus strain isolated from a feral horse in Japan

Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients